A six year experience with the postoperative radiosurgical management of pituitary adenomas

Stereotactic and Functional Neurosurgery

Volumn 72, Issue SUPPL. 1, 1999, Pages 88-100

  Mokry, M ^a,b   Ramschak Schwarzer, S ^a   Simbrunner, J ^a   Ganz, J C ^a   Pendl, G ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acromegaly; Cushing's disease; Gamma Knife; Pituitary adenomas; Prolactinoma; Stereotactic radiosurgery

Indexed keywords

BROMOCRIPTINE; CORTICOTROPIN; GROWTH HORMONE; HORMONE; PROLACTIN; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADOLESCENT; ADULT; AGED; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CUSHING DISEASE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS ADENOMA; IRRADIATION; MAJOR CLINICAL STUDY; MALE; PROLACTINOMA; RADIOSURGERY; STEREOTAXIC SURGERY; TRANSSPHENOIDAL SURGERY; TUMOR VOLUME;

EID: 0033394629     PISSN: 10116125     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056444     Document Type: Conference Paper

References (36)

1. Flickinger JC, Nelson P, Taylor FH, Robinson A: Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer 1989;63:2404-2408.
2. Goffman TE, Dewan R, Arakaki R: Persistent or recurrent acromegaly. Long-term endocrinologic efficacy and neurological safety of postsurgical radiation therapy. Cancer 1992;69:271-275.
3. Hewlett TA, Plowmann PN, Wass JR, Rees LH, Jones AE, Bessner GM: Megavoltage pituitary irradiation in the treatment of Cushing's disease and Nelson's syndrome: Long-term follow-up. Clin Endocrinol 1989;31:309-323.
4. McCollough WM, Marcus RB, Rhoton AL, Ballinger WE, Million ER: Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after >4500 Gy. Int J Radiat Oncol Biol Phys 1991;21:607-614.
5. Moberg E, Trampe E, Wersall J, Werner S: Long-term effects of radiotherapy and bromocryptine treatment in patients with previous surgery for macroprolactinomas. Neurosurgery 1991;29:200-205.
6. Eastman RC, Gordon P, Roth J: Conventional supervoltage irradiation is an effective treatment for acromegaly. J Clin Endocrinol Metab 1979;48:931-940.
7. Feek CM, McLelland J, Seth J: How effective is external pituitary irradiation for growth hormone-secreting pituitary tumors? Clin Endocrinol 1984;20:401-408.
8. Halberg FE, Sheline GE: Radiotherapy of pituitary tumors. Endocrinol Metab Clin North Am 1987;16:667-684.
9. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML: Hypopituitarism following external radiotherapy for pituitary tumors in adults. Quart J Med 1989;70:145-160.
10. Snyder PJ, Fouble BF, Schwartz NJ, Savina PJ, Gennaelli TH: Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 1986;81:457-462.
11. Trampe E, Lundell G, Lax I, Werner S: External irradiation of growth hormone producing pituitary adenomas: Prolactin as a marker of hypothalamic and pituitary effects. Int J Radiat Oncol Biol Phys 1991;20:655-660.
12. Werner S, Trampe EA, Palacios P, Lax I, Hall K: Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation. Int J Radiat Oncol Biol Phys 1985;11:1713-1720.
13. Al-Mefty O, Kersh JE, Routh A, Smith RR: The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 1990;73:502-512.
14. Rähn T, Thorén M, Hall K, Backlund E-O: Stereotactic radiosurgery in Cushing's syndrome. Acute radiation effects. Surg Neurol 1980,:14:85-92.
15. Rähn T, Thorén M, Werner S: Stereotactic radiosurgery in pituitary adenomas. In: Faglia G, Beck-Peccoz P, Ambrosi P, Travaglini P, Spada A, (eds) Pituitary Adenomas: New Trends in Basic and Clinical Research. Amsterdam, Elsevier, 1991, pp303-312.
16. Steiner L, Lindquist C, Steiner M: Radiosurgery. Adv Tech Stand Neurosurg 1992;19:21-97.
17. Grigsby PW, Simpson JR, Fineberg BB: Late regrowth of pituitary adenomas after irradiation and/or surgery. Cancer 1989;63:1308-1312.
18. Grigsby PW, Thomas PR, Simpson JR, Fineberg BB: Long-term results of radiotherapy in the treatment of pituitary adenomas in children and adolescents. Am J Clin Oncol 1988;11:607-611.
19. Sheline GE, Tyrrell JB: Pituitary adenomas. In: Phillips T, Pistenmaa D (eds) Radiation Oncology Annual 1983. New York. Raven Press, 1984, pp1-35.
20. Pollock BE, Kondziolka D, Lunsford LD, Flickinger JC: Stereotactic radiosurgery for pituitary adenomas: Imaging, visual and endocrine results. Acta Neurochir 1994;62:33-38.
21. Ganz JC, Backlund E-O, Thorson FA: The effects of Gamma Knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotact Fund Neurosurg 1993;61(suppl 1):30-37.
22. Samaan NA, Vieto R, Schultz PN, Maor M, Meoz RT, Sampiere VA, et al.: Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck. Int J Radiat Oncol Biol Phys 1982;8:1857-1867.
23. Degerblad M, Rähn T, Bergstrand G, Thorén M: Long term results of stereotactic radiosurgery to the pituitary gland in Cushing's disease. Acta Endocrinol Copenhagen 1986;112:310-314.
24. Morange-Ramos I, Regis J, Dufour H, Andrieu JM, Grisoli F, Jaquet P, et al.: Short-term endocrinological results after Gamma Knife radiosurgery of pituitary adenomas. Stereotact Funct Neuro surg 1997;70(suppl 1):127-138.
25. Thorén M, Rähn T, Hallengren B, Kaad PH, Nilsson KO, Ravn H, et al.: Treatment of Cushing's disease in childhood and adolescence by stereotactic pituitary irradiation. Acta Paediatr Scand 1986;75:388-395.
26. Flickinger JC, Rush SC: Linear accelerator therapy of pituitary adenomas. In: Vance MhL, Reilly PL (Eds.) Pituitary Adenomas. New York, Churchill Livingstone 1996, pp475-483.
27. Guy J, Mancuso A, Beck R, Moster ML, Sedwick LA, Quisling RG, et al.: Radiation-induced optic neuropathy: A magnetic resonance imaging study. J Neurosurg 1991;74:426-432.
28. Kramer S: Indications for, and results of, treatment of pituitary tumors by external radiation. In: Kohler PO, Ross GT, (eds.) Diagnosis and Treatment of Pituitary Tumors. New York, Excerpta Medica American Elsevier, 1973, pp217.
29. Landolt AM: Hazards of radiotherapy in patients with pituitary adenomas. In: Derome P. Jedynak CP, Peillon F (eds.), Pituitary Adenomas. Biology, Physiopathology and Treatment. Rueil-Malmaison: Asclepios, 1980, pp227-232.
30. Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander E, Kooy HM, et al: Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 1993;27:215-212.
31. Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander E III, Kooy H, et al.: Cranial neuropathies following radiosurgery for cavernous sinus lesions. Int J Radiat Oncol Biol Phys 1993; 27:215-221.
32. Leber K, Berglöff J, Pendl G: Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998;88:43-50.
33. Lim YJ, Leem W, Kim TS, Rhee BA, Kim GK: Stereotact Funct Neurosurg 1997;70(suppl 1):95-109.
34. Ganz JC: Gamma Knife treatment of pituitary adenomas. Stereotact Funct Neurosurg 1995; 64(suppl 1):3-10.
35. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, et al.: Stereotactic radiosurgery for recurrent surgically treated acromegaly: Comparison with fractionated radiotherapy. J Neurosurg 1998;88:1002-1008.
36. Ganz JC: Gamma Knife treatment of pituitary adenomas, in Landolt AM, Vance ML, Reilly PL (eds): Pituitary Adenomas. New York, Churchill Livingstone, 1996, pp461-474